Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Nav1.7-IN-3 | 1788872-06-9 | 98.2% | 430.95 g·mol⁻¹ | C17H20ClFN4O2S2 | 25 MG
SDP

Catalog No. 5000246764
Encompass_Preferred

Nav1.7-IN-3 is a selective, orally bioavailable inhibitor of the voltage-gated sodium channel Nav1.7, showing potent activity (IC50 8 nM). The compound is reported to have limited central nervous system penetration and is supplied for research use only.

  • Potent Nav1.7 inhibition (IC50 8 nM).
  • Orally bioavailable profile suitable for in vivo studies.
  • Limited CNS penetration, supporting peripheral pain models.
  • High analytical purity (98.21%).
  • Well-characterized composition (MW 430.95 g·mol⁻¹; formula C17H20ClFN4O2S2).
  • Provided for research use only.

Catalog No. 50-002-46764 Supplier Medchemexpress LLC Supplier No. HY10178925MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nav1.7-IN-3 is a selective, orally bioavailable inhibitor of the voltage-gated sodium channel Nav1.7, showing potent activity (IC50 8 nM). The compound is reported to have limited central nervous system penetration and is supplied for research use only.

  • Potent Nav1.7 inhibition (IC50 8 nM).
  • Orally bioavailable profile suitable for in vivo studies.
  • Limited CNS penetration, supporting peripheral pain models.
  • High analytical purity (98.21%).
  • Well-characterized composition (MW 430.95 g·mol⁻¹; formula C17H20ClFN4O2S2).
  • Provided for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.